Dosing & injections
Restarting a GLP-1 after a break
October 2, 2026 · 6 min read · Medically reviewed by Bryan Milton, MD · Reviewed October 2, 2026
After a gap, clinicians often restart lower and step up again rather than resuming your old dose. Why tolerance resets, and what to expect second time around.
People stop a GLP-1 for all sorts of reasons: supply, cost, a holiday, side effects, a pregnancy plan, or simply losing the thread. Restarting is routine. What is not routine is picking up at the dose you left off, and this is the most common mistake people make on their own.
Why can't I just resume my old dose?
Because the reason the labels titrate in the first place is tolerability, and tolerability is not permanent. The commonly reported gastrointestinal effects cluster in the early weeks of treatment and after each dose increase — in other words, when the body is meeting a dose it is not currently used to. After a long enough gap, your previous maintenance dose is a dose your body is no longer used to, which makes resuming it a step up rather than a continuation.
The practical result is predictable: people who restart high report the nausea and vomiting of early treatment, sometimes worse, and sometimes stop again because of it.
How far back do clinicians usually go?
It depends, and the honest version is that there is no single published rule. What a clinician weighs:
- How long the gap was. A missed week is not a restart; months away is.
- Why you stopped. Side effects point to a slower, lower restart than a supply gap does.
- What dose you were on, and how you tolerated getting there the first time.
- What has changed since: other medications, pregnancy plans, new diagnoses, surgery, weight change.
- What you are restarting for, which may not be what you started for.
What should I expect second time around?
Often an easier run than the first, because you know what the early weeks feel like and what helps. Sometimes a harder one, because a restart can be less tolerable than the original start. Either happens. What is reliable is that the pattern follows dose increases again, so the same tactics apply: smaller portions, lower-fat food in the days after an injection, fluids, and telling your care team early rather than pushing through.
| Your clinician will ask | Why |
|---|---|
| How long since your last dose | It decides whether this is a restart at all |
| Why you stopped | Side effects change the plan more than logistics do |
| What dose you were on | The ceiling to work back toward, not the starting point |
| What else has changed | New medications or plans can change eligibility entirely |
| How the first titration went | Your own history is the best available predictor |
Do I need a new assessment?
Usually something like one, and it is not a formality. The contraindications are about your current circumstances, not the ones you had when you first started: a new diagnosis, a new medication, a pregnancy plan or planned surgery can all change whether treatment is appropriate now. A service that restarts you on request without asking is not screening you.
What about a half-used vial from before?
Check its beyond-use date and storage history before assuming it is usable, and ask the pharmacy if either is uncertain. A compounded preparation's usable life is typically shorter than a manufactured product's, and a vial that sat through a few months of uncertain storage is not where to economise. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
Your own prescription label and the instructions that came with it are the authority on your medication. A compounded preparation can differ from an approved product in concentration, storage and beyond-use date, so where this article and your label disagree, the label wins — and your care team can settle anything unclear.
This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.